Zhao-Kui Wan

Title: Innovations of Zhao-Kui Wan in Thienopyridinone Compounds

Introduction

Zhao-Kui Wan is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thienopyridinone compounds. His research focuses on the development of new compounds that have potential applications in treating various diseases, including cancer.

Latest Patents

Zhao-Kui Wan holds a patent for thienopyridinone compounds. This invention relates to new thienopyridinone compounds, pharmaceutical compositions comprising these compounds, processes for their preparation, and their use as FGFR (fibroblast growth factor receptor) inhibitors. The implications of this research are profound, as these compounds may play a crucial role in the treatment of diseases such as cancer.

Career Highlights

Zhao-Kui Wan is currently associated with Janssen Pharmaceutica NV, a leading pharmaceutical company. His work at Janssen has allowed him to further his research and contribute to the development of innovative treatments in the pharmaceutical industry.

Collaborations

Zhao-Kui Wan has collaborated with notable colleagues, including Luoheng Qin and Haibing Guo. These collaborations have enhanced the scope and impact of his research, fostering a productive environment for innovation.

Conclusion

Zhao-Kui Wan's contributions to the field of pharmaceuticals, particularly through his patent on thienopyridinone compounds, highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for future medical applications.